We are excited to join The ERS Congress, an annual event that brings together the world’s respiratory experts to showcase the latest advances in respiratory medicine and science. This year’s theme, “United for better breathing: partnership between patients, clinicians and researchers”, emphasizes the crucial relationship between respiratory professionals and patients.
Take this opportunity to meet our experts onsite and discover how we can support your evidence generation and market access strategies and help you embed patient voices at every stage of product development. At Alira Health, we design and execute real-world evidence studies to support HTA and market access decision-making, develop innovative patient identification algorithms for complex and rare diseases, and integrate healthcare and environmental data to generate evidence that supports clinical development, demonstrates value, and improves patient access.
Make sure you do not miss our poster presentation! Check below for topic and presentation time.
Eduardo Pérez Engagement Manager, Strategic Patient Engagement and Advocacy
Check Out Our Poster
Public Health Impact of Exposome on COPD and Asthma Exacerbations in France
Monday, September 7, 12:30-14:00 CEST
Poster session: 354
Abstract: Chronic obstructive pulmonary disease (COPD) and asthma exacerbations occurrence is influenced by environmental and socioeconomic factors, also known as exposome. This study aims to assess public health impact of exposome on COPD and asthma severe exacerbations, and the costs associated, in France between 2018 and 2022.
Authors: Colas Tcherakian, Isabella Annesi-Maesano, Christiane Pochulu, Lea Antoniali, Aurélie Chekroun Martinot, Floriane Huret, Véronique Marcadé Fulcrand, Mathieu Rosé, Olivia Carnapete, Thomas Séjourné, Priscille de la Tour, Nicolas Molinari